Barton Shane bought BIOA
June 29, 2026 · Form 4 insider transaction
Barton Shane bought 7,261 shares of BioAge Labs, Inc. at $8.39 per share, a transaction worth $60.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,261
Price
$8.39
Total value
$60.9K
InsiderBarton Shane
RoleOfficer
CompanyBioAge Labs, Inc. (BIOA)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 29, 2026
Filing dateJuly 1, 2026
Shares owned after19,194
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025.